Your browser doesn't support javascript.
loading
Dynamic clonal equilibrium and predetermined cancer risk in Barrett's oesophagus.
Martinez, Pierre; Timmer, Margriet R; Lau, Chiu T; Calpe, Silvia; Sancho-Serra, Maria Del Carmen; Straub, Danielle; Baker, Ann-Marie; Meijer, Sybren L; Kate, Fiebo J W Ten; Mallant-Hent, Rosalie C; Naber, Anton H J; van Oijen, Arnoud H A M; Baak, Lubbertus C; Scholten, Pieter; Böhmer, Clarisse J M; Fockens, Paul; Bergman, Jacques J G H M; Maley, Carlo C; Graham, Trevor A; Krishnadath, Kausilia K.
Afiliación
  • Martinez P; Evolution and Cancer Laboratory, Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, EC1M 6BQ London, UK.
  • Timmer MR; Department of Gastroenterology and Hepatology, Academic Medical Center-University of Amsterdam, 1100 DD Amsterdam, The Netherlands.
  • Lau CT; Center for Experimental and Molecular Medicine, Academic Medical Center-University of Amsterdam, 1100 DD Amsterdam, The Netherlands.
  • Calpe S; Department of Gastroenterology and Hepatology, Academic Medical Center-University of Amsterdam, 1100 DD Amsterdam, The Netherlands.
  • Sancho-Serra Mdel C; Center for Experimental and Molecular Medicine, Academic Medical Center-University of Amsterdam, 1100 DD Amsterdam, The Netherlands.
  • Straub D; Department of Gastroenterology and Hepatology, Academic Medical Center-University of Amsterdam, 1100 DD Amsterdam, The Netherlands.
  • Baker AM; Center for Experimental and Molecular Medicine, Academic Medical Center-University of Amsterdam, 1100 DD Amsterdam, The Netherlands.
  • Meijer SL; Department of Gastroenterology and Hepatology, Academic Medical Center-University of Amsterdam, 1100 DD Amsterdam, The Netherlands.
  • Kate FJ; Center for Experimental and Molecular Medicine, Academic Medical Center-University of Amsterdam, 1100 DD Amsterdam, The Netherlands.
  • Mallant-Hent RC; Department of Gastroenterology and Hepatology, Academic Medical Center-University of Amsterdam, 1100 DD Amsterdam, The Netherlands.
  • Naber AH; Center for Experimental and Molecular Medicine, Academic Medical Center-University of Amsterdam, 1100 DD Amsterdam, The Netherlands.
  • van Oijen AH; Evolution and Cancer Laboratory, Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, EC1M 6BQ London, UK.
  • Baak LC; Department of Pathology, Academic Medical Center-University of Amsterdam, 1100 DD Amsterdam, The Netherlands.
  • Scholten P; Department of Pathology, Academic Medical Center-University of Amsterdam, 1100 DD Amsterdam, The Netherlands.
  • Böhmer CJ; Department of Gastroenterology and Hepatology, Flevoziekenhuis, 1300 EG Almere, The Netherlands.
  • Fockens P; Gastroenterological Association, 1006 AE Amsterdam, The Netherlands.
  • Bergman JJ; Gastroenterological Association, 1006 AE Amsterdam, The Netherlands.
  • Maley CC; Department of Gastroenterology and Hepatology, Tergooiziekenhuizen, 1201 DA Hilversum, The Netherlands.
  • Graham TA; Gastroenterological Association, 1006 AE Amsterdam, The Netherlands.
  • Krishnadath KK; Department of Gastroenterology and Hepatology, Medisch Centrum, 1800 AM Alkmaar, The Netherlands.
Nat Commun ; 7: 12158, 2016 08 19.
Article en En | MEDLINE | ID: mdl-27538785
ABSTRACT
Surveillance of Barrett's oesophagus allows us to study the evolutionary dynamics of a human neoplasm over time. Here we use multicolour fluorescence in situ hybridization on brush cytology specimens, from two time points with a median interval of 37 months in 195 non-dysplastic Barrett's patients, and a third time point in a subset of 90 patients at a median interval of 36 months, to study clonal evolution at single-cell resolution. Baseline genetic diversity predicts progression and remains in a stable dynamic equilibrium over time. Clonal expansions are rare, being detected once every 36.8 patient years, and growing at an average rate of 1.58 cm(2) (95% CI 0.09-4.06) per year, often involving the p16 locus. This suggests a lack of strong clonal selection in Barrett's and that the malignant potential of 'benign' Barrett's lesions is predetermined, with important implications for surveillance programs.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esófago de Barrett / Neoplasias Esofágicas / Adenocarcinoma / Evolución Clonal / Carcinogénesis Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esófago de Barrett / Neoplasias Esofágicas / Adenocarcinoma / Evolución Clonal / Carcinogénesis Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido